ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 12198 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 12198; 2) Community: the network communities that were significantly associated with the response to NSC 12198; 3) Molecule: the relationships between components within communities and NSC 12198; 4) MDR: the compounds that were significantly associated with the NSC 12198.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.0385067071027343 0.20439243
NSC 663337 Null 0.0385067071027343 0.33713023
NSC 666767 Null 0.0385067071027343 0.39221371
NSC 670230 4,5-Dimethyl-11H-pyrido[4,3-a]carbazole 0.0385067071027343 0.24824041
NSC 671404 Null 0.0385067071027343 0.391435
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.0385067071027343 0.31377099
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.0385067071027343 0.14874613
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0385067071027343 0.32211093
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0385067071027343 0.40113617
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.0385067071027343 0.30676135
Total:147  Current:117    [First] [Prev] [Next] [Last]